Edition:
United States

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

28.41USD
14 Dec 2018
Change (% chg)

$-0.15 (-0.53%)
Prev Close
$28.56
Open
$28.51
Day's High
$28.62
Day's Low
$28.28
Volume
179,707
Avg. Vol
126,562
52-wk High
$29.26
52-wk Low
$22.70

Latest Key Developments (Source: Significant Developments)

Fresenius Medical Care CEO Says Actively Evaluating M&A Opportunities
Tuesday, 30 Oct 2018 11:50am EDT 

Oct 30 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS MEDICAL CARE CFO SAYS WE CONTINUE TO ACTIVELY EVALUATE M&A OPPORTUNITIES.FRESENIUS MEDICAL CARE CEO SAYS DOES NOT EXPECT TO NEED TO DO FURTHER DISPOSALS TO CLOSE NXSTAGE DEAL.  Full Article

Nxstage Medical Inc Says Co Agreed To Sell Its Bloodlines Business
Wednesday, 18 Jul 2018 05:13pm EDT 

July 18 (Reuters) - NxStage Medical Inc ::NXSTAGE MEDICAL INC - ON JULY 10, CO AGREED TO SELL ITS BLOODLINES BUSINESS OPERATED UNDER THE MEDISYSTEMS NAME TO B. BRAUN MEDICAL INC.NXSTAGE MEDICAL INC - NXSTAGE CONTINUES TO EXPECT FRESENIUS MERGER TO CLOSE IN 2018 -SEC FILING.  Full Article

NXSTAGE SAYS STOCKHOLDER APPROVE MERGER WITH FRESENIUS MEDICAL CARE
Friday, 27 Oct 2017 12:10pm EDT 

Oct 27 (Reuters) - NxStage Medical ::NXSTAGE ANNOUNCES STOCKHOLDER APPROVAL OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE.‍MERGER IS EXPECTED TO BE COMPLETED IN 2018​.ABOUT 94% OF VOTE CAST AT SPECIAL MEETING OF STOCKHOLDERS VOTED IN FAVOR OF ADOPTION OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE​.  Full Article

UPDATE 2-Fresenius Medical Care says expects weaker growth in Q4

* Deadline for NxStage Medical takeover extended (Adds share price, analyst)